GNOM
Global X Genomics & Biotechnology ETF [GNOM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GNOM Stock Summary
Top 10 Correlated ETFs
GNOM
Top 10 Correlated Stocks
GNOM
In the News
GNOM Financial details
Company Rating
-
Market Cap
100.61M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
12.7%
SMA50
19.4%
SMA100
35.02%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.63-13.33
52W High
+228.55%
52W Low
+433.9%
RSI
70.57
Rel Volume
0.1
Avg Volume
73.96K
Volume
7.71K
Perf Week
1.5%
Perf Month
12.43%
Perf Quarter
31.66%
Perf Half Y
40.87%
-
-
-
-
Beta
1.19
-
-
Volatility
0.79%, 2.13%
Prev Close
-0.67%
Price
42.7117
Change
-1.11%
Company Profile
- Volume Average 73.96K
- Market Capitalization 100.61M
- Headquarters US
- IPO Date 2019-04-10
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
